about
Suppression of the antiviral response by an influenza histone mimicDissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 bindingHost modulators of H1N1 cytopathogenicityMutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells.Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal modelsMutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus.Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 proteinPandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species.Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potentialInfluenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cellsGlycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza virusesInfluenza A virus uses intercellular connections to spread to neighboring cellsMeta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding.An enzymatic virus-like particle assay for sensitive detection of virus entryPan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunityAnalysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virusEngineered RNA viral synthesis of microRNAsβ-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cellsInhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export.Cross-presenting CD103+ dendritic cells are protected from influenza virus infection.Characterization of the LDL-A module mutants of Tva, the subgroup A Rous sarcoma virus receptor, and the implications in protein folding.Expression of Ebolavirus glycoprotein on the target cells enhances viral entryInsertion of a GFP reporter gene in influenza virus.RIG-I detects mRNA of intracellular Salmonella enterica serovar Typhimurium during bacterial infection.Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species.Stabilization and Improvement of a Promising Influenza Antiviral: Making a PAIN PAINless.La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocationCharacterization of the receptor-binding domain of Ebola glycoprotein in viral entry.Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.Characterization of Marburg virus glycoprotein in viral entry.Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus.Igβ ubiquitination activates PI3K signals required for endosomal sorting.Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein.Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis.Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity.Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication.A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Luciferase
P50
Q24307599-9AC41D0B-4A10-4D7F-BDED-C5F005CCC7EDQ27485638-4A718431-F7CF-4A90-A043-79F83BA958EBQ28481798-2F7D49C7-75C5-479D-BC55-7E21E44E5133Q30366669-A5E391A6-ADB9-42B4-87CD-2F0A5DE6AD4CQ30385271-3E67DAE2-69F2-44CB-828A-3EC4A1219445Q30385984-F69ACC0C-576D-4AE4-8283-9ABE4FDFB5AEQ30386800-EDBBAAD8-35CA-4F96-B8E6-4C9AF03380F0Q30388846-7E2E1D19-A49C-4FED-A439-379A6BE03706Q30395264-64F67BFD-F119-4C9E-AB68-555127ADDBF4Q30395286-50F00227-F6EE-4E9C-B237-1ED43EE0C3F6Q30406151-FE735161-4A46-45BB-8129-7EBDECC74817Q30417679-F0904576-9FE4-4C21-86B5-147767049E16Q30424573-85BBBF1D-E304-42F6-B9DF-C914014141BFQ30431220-7BC789A2-1730-465C-B8C4-19607C188D24Q30616850-13345D96-B35E-43A2-9437-FBD562F1BD83Q31031297-A2B984C7-26C6-408B-B271-17FA739486FFQ33624624-C537B126-2C42-47FD-A8B1-D1F5053CD0CBQ33830730-5F4C5230-2BB8-44D3-AEF1-F502AF1FB52DQ33953302-0809C48E-8FDE-4FC6-8D16-53B6EF1B6FD0Q33953313-C40899AC-157C-4C37-8D6F-186D3100C048Q35096982-25A5F788-D141-4F41-A4EF-2CAD7F105820Q35744520-D3EE204D-9C64-4CED-A4F2-4EE253C8CFEAQ36357778-B7E57850-BBD5-4610-816B-D7F3B80AF7FCQ36639604-1AE51E78-09C1-4CEE-90A0-C203196E4367Q37234907-A3EC648D-2D0F-4BE1-A7A6-8C48E83C3073Q37426741-924AB9EC-C2EC-4F3E-B671-52ECDF391618Q37687826-FFCBD513-CF99-4FAD-B461-308DAF5A2DE7Q37716213-535B969C-5C8C-4235-9B5F-D25FE17D8FF9Q38809058-3AFBC24E-83DA-4932-86E6-C61489C8ECCEQ38821414-F6DA241B-7B8D-444C-8829-2970CF3E6995Q39525695-CBF66E24-BA9E-4B5D-8DF8-7EA62AC19DE5Q39796114-AE315122-5E3D-4A68-A289-295E639B7224Q40228983-A222F6C9-33FE-48BE-B1C0-E78C75E0843FQ44105897-99B4F47D-EFB6-48C4-9F7C-44AF9E4B43E1Q46075584-3CFDD43B-601E-4EB3-8657-ADD751039C9CQ47264095-687F4604-897D-4544-B79A-9C7EAD3A6F53Q47555954-2D64F96C-5DEA-43CC-B410-D7F5AFC137D3Q50996942-78E5CDF3-D01A-4008-9BB4-A979EABE4A23Q52431468-839EB4AC-E786-4322-B6C0-FFA704E182A2Q56477377-3F8DED14-98D5-4C06-9517-8228B09B61C9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Balaji Manicassamy
@ast
Balaji Manicassamy
@en
Balaji Manicassamy
@es
Balaji Manicassamy
@nl
type
label
Balaji Manicassamy
@ast
Balaji Manicassamy
@en
Balaji Manicassamy
@es
Balaji Manicassamy
@nl
prefLabel
Balaji Manicassamy
@ast
Balaji Manicassamy
@en
Balaji Manicassamy
@es
Balaji Manicassamy
@nl
P106
P31
P496
0000-0003-1964-0967